|

VRT106 Clinical Trials

3 actively recruiting trials

Pipeline

Phase 1: 2Phase 1/2: 1

Top Sponsors

  • Guangzhou Virotech Pharmaceutical Co., Ltd.3

Indications

  • Cancer3
  • Solid Tumors1
  • Solid Tumor1
  • Glioblastoma1

Other3 trials

A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors
Phase 1
A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors
Phase 1
A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.